This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Changzhou Le Sun Pharmaceuticals Limited. Active years: 2014.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2014
Title: The Innovative Contributions of Osama Chahrour
Introduction
Osama Chahrour is a notable inventor based in Nottinghamshire, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds for treating proliferative disorders. His work is characterized by a focus on innovative solutions that address critical health challenges.
Latest Patents
Chahrour holds a patent for "Compounds for treating proliferative disorders." This patent describes a compound of formula (I) or its pharmaceutically acceptable derivatives, which can be utilized for treating conditions mediated by various enzymes associated with cancer and other proliferative disorders. The compound is designed to inhibit the growth of cancer cells and induce apoptosis in a human or animal subject.
Career Highlights
Osama Chahrour is currently employed at Changzhou Le Sun Pharmaceuticals Limited. His role at the company allows him to engage in cutting-edge research and development, contributing to advancements in medical treatments. His patent reflects his commitment to improving health outcomes through innovative pharmaceutical solutions.
Collaborations
Chahrour has collaborated with notable colleagues such as Shudong Wang and Tiangong Lu. These partnerships enhance the research and development process, fostering an environment of innovation and shared expertise.
Conclusion
Osama Chahrour's work exemplifies the impact of innovation in the pharmaceutical industry. His contributions, particularly through his patent, highlight the importance of developing effective treatments for proliferative disorders. His ongoing efforts at Changzhou Le Sun Pharmaceuticals Limited continue to pave the way for advancements in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile